Susanne Renz

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Top Venues

BMJ (Clinical research ed.)

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Miriam Santer, Megan Lawrence, Sarah Pyne, Susanne Renz, Beth L Stuart, Tracey H Sach, Matthew J Ridd, Kim Suzanne Thomas, Jacqueline Nuttall, Natalia Permyakova, Zina Eminton, Nick A Francis, Paul Little, Ingrid Muller, Irene Soulsby, Karen Thomas, Gareth O Griffiths, Alison Margaret Layton
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT. Health technology assessment (Winchester, England) 28 (56) (2024)
Miriam Santer, Megan Lawrence, Susanne Renz, Zina Eminton, Beth L Stuart, Tracey H Sach, Sarah Pyne, Matthew J Ridd, Nick A Francis, Irene Soulsby, Karen Thomas, Natalia Permyakova, Paul Little, Ingrid Muller, Jacqueline Nuttall, Gareth O Griffiths, Kim Suzanne Thomas, Alison Margaret Layton, null null
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ (Clinical research ed.) 381 (2023)
Miriam Santer, Megan Lawrence, Susanne Renz, Zina Eminton, Beth L Stuart, Tracey H Sach, Sarah Pyne, Matthew J Ridd, Nick A Francis, Irene Soulsby, Karen Thomas, Natalia Permyakova, Paul Little, Ingrid Muller, Jacqueline Nuttall, Gareth O Griffiths, Kim Suzanne Thomas, Alison Margaret Layton, null null
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ (Clinical research ed.) 381 (2023)
Susanne Renz, Fay Chinnery, Beth Stuart, Laura Day, Ingrid Muller, Irene Soulsby, Jacqui Nuttall, Karen Thomas, Kim Suzanne Thomas, Tracey Sach, Louise Stanton, Matthew J Ridd, Nick A Francis, Paul Little, Zina Eminton, Gareth Griffiths, Alison M Layton, Miriam Santer
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women. BMJ open 11 (8) (2021)